Explore more topics
News sentiment

Unicycive Therapeutics, Inc. Common Stock (UNCY) news sentiment

How positive or negative Unicycive Therapeutics, Inc. Common Stock's news headlines have been since Jul 12, 2021, week by week, with the last 90 sessions day by day and each recent headline's tone and source.

As of 2026-10-29

Average tone, last 30 sessions
-8From -100 (every headline negative) to +100 (every headline positive)
Headlines, last 30 sessions
149
Headlines, last 90 sessions
211
Change from the 90-session average
0
Latest session
2026-10-29

Weekly headline tone since July 2021

Hover a week for its biggest stories; click to pin.

Tone8-week averageHeadlinesFiltered out (passing mentions)
Every week since Jul 12, 2021
UNCY headline tone: Every week since Jul 12, 2021, 137 weeks from July 12, 2021 to October 19, 2026.-100-75-50-25+25+50+75+1000Headlines20222023202420252026

Coverage of Unicycive Therapeutics, Inc. Common Stock over the last 30 trading sessions is negative (-8) across 149 headlines, 2 points above its one-year average of -10. The most widely carried story in the week of Oct 19, 2026 was "Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate NDA Resubmission and PDUFA Date of March 25, 2027", carried by 4 outlets.

Each point is one week of headlines about Unicycive Therapeutics, Inc. Common Stock: the share of positive minus negative headlines, from -100 to +100, with the 8-week average drawn through it and the number of headlines beneath. Since coverage began, 565 headlines average 0.

Jump to a section

Tone mix

UNCY headlines by tone, last 52 weeks
positive
7%
neutral
75%
negative
18%

Week by week 49 weeks

Apr 28, 2025: 0 positive, 1 neutral, 0 negativeMay 12, 2025: 0 positive, 2 neutral, 0 negativeMay 19, 2025: 0 positive, 2 neutral, 0 negativeJun 9, 2025: 0 positive, 0 neutral, 4 negativeJun 16, 2025: 0 positive, 0 neutral, 1 negativeJul 21, 2025: 1 positive, 1 neutral, 0 negativeJul 28, 2025: 0 positive, 2 neutral, 0 negativeAug 11, 2025: 0 positive, 2 neutral, 0 negativeAug 18, 2025: 2 positive, 13 neutral, 0 negativeAug 25, 2025: 0 positive, 12 neutral, 1 negativeSep 1, 2025: 0 positive, 9 neutral, 1 negativeSep 8, 2025: 0 positive, 9 neutral, 4 negativeSep 15, 2025: 0 positive, 14 neutral, 4 negativeSep 22, 2025: 0 positive, 11 neutral, 1 negativeSep 29, 2025: 0 positive, 14 neutral, 6 negativeOct 6, 2025: 0 positive, 14 neutral, 6 negativeOct 13, 2025: 2 positive, 10 neutral, 5 negativeOct 27, 2025: 0 positive, 4 neutral, 0 negativeNov 3, 2025: 1 positive, 1 neutral, 0 negativeNov 10, 2025: 0 positive, 3 neutral, 0 negativeNov 17, 2025: 0 positive, 0 neutral, 1 negativeNov 24, 2025: 0 positive, 1 neutral, 0 negativeDec 1, 2025: 0 positive, 1 neutral, 0 negativeDec 8, 2025: 0 positive, 1 neutral, 0 negativeDec 22, 2025: 0 positive, 1 neutral, 0 negativeDec 29, 2025: 1 positive, 0 neutral, 0 negativeJan 12, 2026: 0 positive, 2 neutral, 0 negativeJan 26, 2026: 2 positive, 1 neutral, 0 negativeFeb 2, 2026: 0 positive, 1 neutral, 0 negativeFeb 9, 2026: 0 positive, 1 neutral, 0 negativeFeb 16, 2026: 1 positive, 0 neutral, 0 negativeMar 30, 2026: 0 positive, 1 neutral, 0 negativeApr 6, 2026: 0 positive, 2 neutral, 0 negativeApr 13, 2026: 0 positive, 1 neutral, 0 negativeMay 11, 2026: 0 positive, 1 neutral, 1 negativeJun 29, 2026: 2 positive, 2 neutral, 4 negativeJul 6, 2026: 1 positive, 1 neutral, 1 negativeJul 13, 2026: 0 positive, 1 neutral, 0 negativeJul 20, 2026: 0 positive, 1 neutral, 0 negativeAug 10, 2026: 1 positive, 2 neutral, 0 negativeAug 17, 2026: 1 positive, 0 neutral, 1 negativeAug 31, 2026: 0 positive, 2 neutral, 0 negativeSep 7, 2026: 0 positive, 17 neutral, 3 negativeSep 14, 2026: 1 positive, 21 neutral, 3 negativeSep 21, 2026: 0 positive, 26 neutral, 3 negativeSep 28, 2026: 3 positive, 22 neutral, 4 negativeOct 5, 2026: 0 positive, 20 neutral, 3 negativeOct 12, 2026: 0 positive, 12 neutral, 3 negativeOct 19, 2026: 7 positive, 20 neutral, 7 negative
Apr 28, 2025Oct 19, 2026

Share of Unicycive Therapeutics, Inc. Common Stock's 378 headlines over the last 52 weeks by the model's call, and the same mix week by week.

Biggest swings in the last year

The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.

Daily headline tone, last 90 sessions

Hover a session for its totals; click to pin.

Session tone8-session averageHeadlines
Last 51 sessions with a headline
UNCY average headline tone by session: Last 51 sessions with a headline, 51 sessions from June 29, 2026 to October 29, 2026.-100-75-50-25+25+50+75+1000HeadlinesJun 2026JulAugSepOct

Each point is the average score of the headlines about Unicycive Therapeutics, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.

Tone by period

Show the table · 3 rows, 3 columns

Scroll sideways to compare all columns. Select a heading to sort.

Last 7 sessions400
Last 30 sessions149-8
Last 90 sessions211-8

Every headline in the period counts equally.

Headlines on Thursday, October 29, 2026

3 headlines, average tone 0: 0 positive, 3 neutral and 0 negative. Showing all 3.

Show the table · 3 rows, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

Securities Lawsuit Alert: Unicycive Therapeutics, Inc. (UNCY) Investors ...www.pr-inside.com1Neutral
UNCY Shareholder Alert: November 2, 2026 Lead Plaintiff Deadline in Unicycive Therapeutics, Inc. Securities Class Actionwww.prnewswire.com1Neutral
Unicycive Therapeutics, Inc. (UNCY) Class Action Lawsuit: Levi & Korsinsky ...www.pr-inside.com1Neutral

Headlines on Wednesday, October 28, 2026

7 headlines, average tone -28: 0 positive, 5 neutral and 2 negative. Showing all 7.

Show the table · 7 rows, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

Class Action Lawsuit Filed Against Unicycive Therapeutics, Inc. (UNCY) ...www.pr-inside.com1Negative
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) Over ...www.pr-inside.com1Negative
Securities Lawsuit Alert: Unicycive Therapeutics, Inc. (UNCY) Investors ...www.pr-inside.com1Neutral
Kaplan Fox Encourages Investors of Unicycive Therapeutics, Inc. (NASDAQ: ...www.pr-inside.com1Neutral
Unicycive Therapeutics, Inc. (UNCY) Class Action Lawsuit: Levi & Korsinsky ...www.pr-inside.com1Neutral
Levi & Korsinsky Urges Unicycive Therapeutics, Inc. (UNCY) Shareholders ...www.pr-inside.com1Neutral
Join Class Action to Recover Losses From Unicycive Therapeutics, Inc. ...www.pr-inside.com1Neutral

Headlines on Tuesday, October 27, 2026

1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.

Show the table · 1 row, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

Investor Alert: Deadline Approaching to Join Unicycive Therapeutics, ...www.pr-inside.com1Neutral

Headlines on Monday, October 26, 2026

5 headlines, average tone -20: 0 positive, 4 neutral and 1 negative. Showing all 5.

Show the table · 5 rows, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

What's Next for Unicycive Therapeutics, Inc. Shareholders After 39.1% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadlinewww.prnewswire.com2Negative
Unicycive Deadline: UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuitwww.prnewswire.com2Neutral
Levi & Korsinsky Urges Unicycive Therapeutics, Inc. (UNCY) Shareholders ...www.pr-inside.com1Neutral
Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. (UNCY) Investors ...www.pr-inside.com1Neutral
UNCY Shareholder Alert: Unicycive Therapeutics, Inc. Securities Class ...www.pr-inside.com1Neutral

Headlines on Friday, October 23, 2026

6 headlines, average tone 0: 2 positive, 2 neutral and 2 negative. Showing all 6.

Show the table · 6 rows, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate NDA Resubmission and PDUFAwww.briefingwire.com1Positive
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate NDA Resubmission and PDUFA Date of March 25, 2027www.jcnnewswire.com1Positive
What Does Unicycive Therapeutics, Inc.'s 39.1% Stock Drop Mean for Investors? The Law Offices of Howard G. Smith Outlines Securities Fraud Class Action Lead Plaintiff Deadlinewww.prnewswire.com1Negative
Class Action Lawsuit Filed Against Unicycive Therapeutics, Inc. (UNCY) ...www.pr-inside.com1Negative
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Urged to Join Class ...www.pr-inside.com1Neutral
Kaplan Fox Reminds Investors of Unicycive Therapeutics, Inc. (NASDAQ: ...www.pr-inside.com1Neutral

How the score works

A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.

  1. Which headlines count

    Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Unicycive Therapeutics, Inc. Common Stock, not a passing mention.

  2. How each headline is scored

    The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).

  3. When a headline counts

    Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.

  4. Repeated stories

    When several outlets carry the same headline, it counts once per session.